Aquatic Capital Management LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1803916 CHICAGO, IL

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,659,944

-$5,617,209 QoQ

Shares Held

15,480

-50.2% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#246

of 784 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aquatic Capital Management LLC holds $144,356,048 across 88 Biotechnology names. ALNY ranks #7 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	32,577	$20,313,062
2	CYTK	Cytokinetics Inc	125,090	$10,656,417
3	TVTX	Travere Therapeutics, Inc.	157,710	$8,959,505
4	ARGX	Argenx SE	7,697	$7,141,045
5	PTCT	Ptc Therapeutics, Inc.	83,470	$6,808,647
6	TGTX	Tg Therapeutics, Inc.	99,530	$5,468,178
7	ALNY	Alnylam Pharmaceuticals, Inc. This page	15,480	$4,659,944
8	MIRM	Mirum Pharmaceuticals, Inc.	36,670	$4,292,956

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,659,944	15,480	-50.2%	Shares	Sole	2026-08-14
2026-03-31	$10,277,153	31,061	-63.0%	Shares	Sole	2026-05-15
2025-09-30	$38,330,904	84,059	+485.9%	Shares	Sole	2025-11-14
2025-03-31	$3,874,246	14,348	-64.6%	Shares	Sole	2025-05-15
2024-12-31	$9,542,291	40,552	+98.7%	Shares	Sole	2025-02-14
2024-09-30	$5,613,087	20,409	+537.8%	Shares	Sole	2024-11-14
2024-06-30	$777,600	3,200	-85.3%	Shares	Sole	2024-08-14
2024-03-31	$3,258,010	21,800	+4.3%	Shares	Sole	2024-05-15
2023-12-31	$4,000,469	20,900	+16.8%	Shares	Sole	2024-02-14
2023-09-30	$3,170,090	17,900	-16.0%	Shares	Sole	2023-11-14
2023-03-31	$4,266,816	21,300	+10550.0%	Shares	Sole	2023-05-15
2022-03-31	$32,658	200	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.